NEULANDLAB

NEULAND LABORATORIES

Small Cap BSE: 524558 NSE: NEULANDLAB
₹1300.00
6.7 (0.52%)
As on 30 September, 2022 | 02:11

Neuland Laboratories Share Price

Neuland Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in NEULAND LABORATORIES

Start SIP

Neuland Laboratories Share Returns

  • Over 1 Month 6.11%
  • Over 3 Month 9.8%
  • Over 6 Month 27.95%
  • Over 1 Year -17.5%

Neuland Laboratories Key Statistics

P/E Ratio 25.8
PEG Ratio -2.1
Market Cap Cr 1,668
Price to Book Ratio 2
EPS 50.6
Dividend 0.4
Relative Strength Index 54.77
Money Flow Index 78.7
MACD Signal 28.58
Average True Range 65.79

Neuland Laboratories Investment Rating

  • Master Rating:
  • Neuland Laboratories has an operating revenue of Rs. 971.36 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 9% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 12%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Neuland Laboratories Financials
IndicatorJun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 221256236258201245
Operating Expenses Qtr Cr 193217204215175219
Operating Profit Qtr Cr 283932432625
Depreciation Qtr Cr 131213121211
Interest Qtr Cr 333445
Tax Qtr Cr 325737
Net Profit Qtr Cr 10221320917

Neuland Laboratories Technicals

EMA & SMA

Current Price
1294.5
1.2 (0.09%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 1270.39
  • 50 Day
  • 1232.03
  • 100 Day
  • 1223.77
  • 200 Day
  • 1256.9
  • 20 Day
  • 1262.56
  • 50 Day
  • 1226.77
  • 100 Day
  • 1166.59
  • 200 Day
  • 1254.42

Neuland Laboratories Resistance and Support

PIVOT
₹1288.04
Resistance
First Resistance 1315.32
Second Resistance 1337.34
Third Resistance 1364.62
RSI 54.77
MFI 78.7
MACD Single Line 28.58
MACD 31.74
Support
First Resistance 1266.02
Second Resistance 1238.74
Third Resistance 1216.72

Neuland Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 30,612 708,668 23.15
Week 94,790 1,739,400 18.35
1 Month 82,908 2,022,116 24.39
6 Month 54,418 1,866,546 34.3

Neuland Laboratories Result Highlights

Neuland Laboratories Synopsis

NSE-Medical-Diversified

Neuland Laborat is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 951.08 Cr. and Equity Capital is Rs. 12.90 Cr. for the Year ended 31/03/2022. Neuland Laboratories Ltd. is a Public Limited Listed company incorporated on 07/01/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004393 and registration number is 004393.
Market Cap 1,661
Sales 971
Shares in Float 0.82
No of funds 48
Yield 0.39
Book Value 2
U/D Vol ratio 1.3
LTDebt / Equity 12
Alpha -0.01
Beta 0.69

Neuland Laboratories

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 36.22%36.22%36.22%
Mutual Funds 0.79%0.79%0.79%
Foreign Portfolio Investors 17.37%17.19%17.19%
Financial Institutions/ Banks
Individual Investors 33.25%32.42%32.84%
Others 12.37%13.38%12.96%

Neuland Laboratories Management

Name Designation
Dr. Davuluri Rama Mohan Rao Executive Chairman
Mr. Davuluri Sucheth Rao Vice Chairman & CEO
Mr. Davuluri Saharsh Rao Vice Chairman & Mng.Director
Dr. Christopher M Cimarusti Non Executive Director
Mr. Humayun Dhanrajgir Ind. Non-Executive Director
Mrs. Bharati Rao Ind. Non-Executive Director
Dr. Nirmala Murthy Ind. Non-Executive Director
Mr. Parampally Vasudeva Maiya Ind. Non-Executive Director
Mr. Homi Rustum Khusrokhan Ind. Non-Executive Director

Neuland Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Neuland Laboratories Corporate Action

Date Purpose Remarks
2022-08-03 Quarterly Results
2022-05-10 Audited Results & Final Dividend
2022-02-01 Quarterly Results
2021-10-29 Quarterly Results
2021-08-03 Quarterly Results
Date Purpose Remarks
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend

Neuland Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 2079
Motilal Oswal S&P BSE Healthcare ETF 6

Neuland Laboratories FAQs

What is Share Price of Neuland Laboratories ?

Neuland Laboratories share price is ₹1300 As on 30 September, 2022 | 01:57

What is the Market Cap of Neuland Laboratories ?

The Market Cap of Neuland Laboratories is ₹1667.9 Cr As on 30 September, 2022 | 01:57

What is the P/E ratio of Neuland Laboratories ?

The P/E ratio of Neuland Laboratories is 25.8 As on 30 September, 2022 | 01:57

What is the PB ratio of Neuland Laboratories ?

The PB ratio of Neuland Laboratories is 2 As on 30 September, 2022 | 01:57

Q1FY23